Search results
Results from the WOW.Com Content Network
The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation ...
An advantage of Lilly launching a split now is this would open the stock up to more investors at a time when growth is going strong -- and this growth easily could power more share-price ...
Even Lilly's closest competitor, Novo Nordisk, completed a 2-for-1 stock split last September. Considering the high price tag for just one share of Lilly stock, some investors may be discouraged ...
Eli Lilly hasn't done a stock split in decades. For premium support please call: 800-290-4726 more ways to reach us
With Eli Lilly posting strong financials and its top GLP-1 drugs still in their early growth stages, there are plenty of reasons to remain bullish on the stock when looking at it over the long haul.
2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (NYSE: LLY).At one point, share prices had gained as much as 65% on the year. However, after a less-than-spectacular earnings ...
Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has helped boost its market capitalization to around $650 billion.
During Q3, Eli Lilly brought in $11.4 billion in sales, up 20% from a year prior, and non-GAAP (adjusted) EPS of $1.18, which was $0.29 less than what the average of Wall Street analysts had ...